CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin

CX3CL1 (fractalkine) and its receptor CX3CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin

Fractalkine interactions with its receptor, CX3CR1, regulate CD4+ T cell retention in atopic dermatitis and offer a potential therapeutic target in allergic disease.

Bibliographic Details
Main Authors: Staumont-Sallé, Delphine, Fleury, Sébastien, Lazzari, Anne, Molendi-Coste, Olivier, Hornez, Nicolas, Lavogiez, Céline, Kanda, Akira, Wartelle, Julien, Fries, Anissa, Pennino, Davide, Mionnet, Cyrille, Prawitt, Janne, Bouchaert, Emmanuel, Delaporte, Emmanuel, Glaichenhaus, Nicolas, Staels, Bart, Julia, Valérie, Dombrowicz, David
Format: Online
Language:English
Published: The Rockefeller University Press 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042636/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042636/

Similar Items